Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Orascom Development - Sponsored Research (ODHN.S)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2021-09-0611.4012.10Neutral
2021-12-1011.0012.05Neutral
2022-05-098.549.45Neutral
2022-10-246.807.20Neutral
2023-02-167.607.65Neutral
2024-01-234.535.10Neutral
2024-03-064.334.60Neutral
2024-07-034.284.20Neutral
2024-11-283.884.00Neutral

Disclosures

  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS has entered into a contract with SIX whereby UBS may (at its discretion) provide research coverage about issuers nominated by SIX. Under the terms of that contract UBS will receive a flat fee of CHF 30,000 per annum from SIX for a period of two years from the time of initiation for the creation and dissemination of research about the relevant issuer. This issuer is covered by UBS pursuant to that contract.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.